Advances in Custom Synthesis - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Advances in Custom Synthesis
As contract manufacturers and drug companies meet at Informex, the stage is set for the latest in pharmaceutical chemical development.

Pharmaceutical Technology
Volume 34, Issue 2, pp. 46-51


1. B. Wu, J.R. Parquette, T.V. RajanBabu, Science 362 (5960), 1662 (2009).

2. C. Kanta De, E.G. Klauber, and D. Seidel, J. Amer. Chem. Soc. 131 (47), 17060–17061 (2009).

3. C. Drahl, Chem. Engin. News 88 (2), 5 (2010).

4. I.B. Seiple et al. Agnew. Chem. Intel. Ed. Engl., DOI://10:1002/anie.200907112 (2010).

5. J. Quan Yu et al., Science 327 (5963), 315–319 (2010).

6. I. Andrews et al., Org. Process Res. Dev. 14 (1), 19–29 (2010).

7. P. Van Arnum, "Deploying Green Chemistry in API Synthesis," Pharm. Technol. Sourcing and Management, July 8, 2009,

8. EPA, Green Chemistry Challenge Agency Awards Program: Summary of 2009 Award Entries and Recipients (Washington, DC, 2009).

9. B.H. Lipshutz et al., Org. Lett. 10 (7), 1325–1328 (2008).

10. B.H. Lipshutz et al., Org. Lett. 10 (7), 1329–1332 (2008).

11. B.H. Lipshutz et al., Org. Lett. 10 (7), 1333–1336 (2008).

12. L.R. MacGillivray, J. Org. Chem. 73 (9), 3311–3317 (2008).

13. L.R. MacGillivray et al., Acc. Chem. Res. 41 (2), 280–291 (2008).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here